Fasudil, a Rho kinase inhibitor, attenuates cardiovascular changes in an experimental rat model of metabolic syndrome via modulation of PCSK9 and BNP

Saved in:
Bibliographic Details
Published inFayoum University Medical Journal (Online) Vol. 13; no. 2; pp. 99 - 110
Main Authors Shamardl, Hanan, Nageeb, Samar, Sadik, Sawsan, Helal, Ayman, Shabana, Mona
Format Journal Article
LanguageEnglish
Published 01.04.2024
Online AccessGet full text

Cover

More Information
ISSN:2536-9482
2536-9482
DOI:10.21608/fumj.2024.259818.1309